The Journal of Immunology, Vol 154, Issue 4 1699-1706, Copyright © 1995 by American Association of Immunologists

ARTICLES

Lymphoid expression and regulation of A20, an inhibitor of programmed cell death

M Tewari, FW Wolf, MF Seldin, KS O'Shea, VM Dixit and LA Turka
Graduate Program in Cellular and Molecular Biology, University of Michigan Medical School, Ann Arbor 48109.

A20 is a cytokine-inducible primary response gene that encodes a protein that inhibits apoptosis. We cloned and characterized a murine A20 cDNA and mapped the gene to mouse chromosome 10, 3.5 centimorgans proximal to the c-myb locus. Using the murine cDNA, we conducted in situ hybridization studies to examine patterns of A20 expression in mouse embryos and postnatal tissues. Both temporally restricted and tissue-specific patterns of A20 expression were observed, with strikingly high levels in lymphoid organs, including the thymus, spleen, and gut-associated lymphoid tissue. Northern analysis using purified human lymphocyte populations demonstrated that A20 is constitutively expressed in both immature and mature thymocyte subpopulations, as well as in resting peripheral T cells. Activation leads to a down-regulation of A20 expression in both mature thymocytes and peripheral T cells. This pattern of expression and regulation differs markedly from that observed in prior studies with cell lines in which stimulation led to an induction of A20 expression. Additionally, this is the first demonstration of constitutive expression of A20 in primary cells. The data suggest a role for A20 in the function of the lymphoid system.

This article has been cited by other articles:

				M. V. Shah, R. Zhang, R. Irby, R. Kothapalli, X. Liu, T. Arrington, B. Frank, N. H. Lee, and T. P. Loughran Jr Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes Blood, August 1, 2008; 112(3): 770 - 781. [Abstract] [Full Text] [PDF]

				M. Malewicz, N. Zeller, Z. B. Yilmaz, and F. Weih NF{kappa}B Controls the Balance between Fas and Tumor Necrosis Factor Cell Death Pathways during T Cell Receptor-induced Apoptosis Via the Expression of Its Target Gene A20 J. Biol. Chem., August 29, 2003; 278(35): 32825 - 32833. [Abstract] [Full Text] [PDF]

				S. T. Grey, C. Longo, T. Shukri, V. I. Patel, E. Csizmadia, S. Daniel, M. B. Arvelo, V. Tchipashvili, and C. Ferran Genetic Engineering of a Suboptimal Islet Graft with A20 Preserves {beta} Cell Mass and Function J. Immunol., June 15, 2003; 170(12): 6250 - 6256. [Abstract] [Full Text] [PDF]

				A. Silkov, O. Wolstein, I. Shachar, and R. Dikstein Enhanced Apoptosis of B and T Lymphocytes in TAFII105 Dominant-negative Transgenic Mice Is Linked to Nuclear Factor-kappa B J. Biol. Chem., May 10, 2002; 277(20): 17821 - 17829. [Abstract] [Full Text] [PDF]

				N. Chen, Q.-B. She, A. M. Bode, and Z. Dong Differential Gene Expression Profiles of Jnk1- and Jnk2-deficient Murine Fibroblast Cells Cancer Res., March 1, 2002; 62(5): 1300 - 1304. [Abstract] [Full Text] [PDF]

				B. B Aggarwal Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappa B Ann Rheum Dis, November 1, 2000; 59(90001): i6 - 16. [Abstract] [Full Text] [PDF]

				E. G. Lee, D. L. Boone, S. Chai, S. L. Libby, M. Chien, J. P. Lodolce, and A. Ma Failure to Regulate TNF-Induced NF-kappa B and Cell Death Responses in A20-Deficient Mice Science, September 29, 2000; 289(5488): 2350 - 2354. [Abstract] [Full Text]

				S. K. Manna and B. B. Aggarwal Lipopolysaccharide Inhibits TNF-Induced Apoptosis: Role of Nuclear Factor-{kappa}B Activation and Reactive Oxygen Intermediates J. Immunol., February 1, 1999; 162(3): 1510 - 1518. [Abstract] [Full Text] [PDF]

				C. Ferran, D. M. Stroka, A. Z. Badrichani, J. T. Cooper, C. J. Wrighton, M. Soares, S. T. Grey, and F. H. Bach A20 Inhibits NF-kappa B Activation in Endothelial Cells Without Sensitizing to Tumor Necrosis Factor-Mediated Apoptosis Blood, April 1, 1998; 91(7): 2249 - 2258. [Abstract] [Full Text] [PDF]

				J. T. Cooper, D. M. Stroka, C. Brostjan, A. Palmetshofer, F. H. Bach, and C. Ferran A20 Blocks Endothelial Cell Activation through a NF-kappa B-dependent Mechanism J. Biol. Chem., July 26, 1996; 271(30): 18068 - 18073. [Abstract] [Full Text] [PDF]

				A. Yamit-Hezi, S. Nir, O. Wolstein, and R. Dikstein Interaction of TAFII105 with Selected p65/RelA Dimers Is Associated with Activation of Subset of NF-kappa B Genes J. Biol. Chem., June 9, 2000; 275(24): 18180 - 18187. [Abstract] [Full Text] [PDF]

				S. Van Huffel, F. Delaei, K. Heyninck, D. De Valck, and R. Beyaert Identification of a Novel A20-binding Inhibitor of Nuclear Factor-kappa B Activation Termed ABIN-2 J. Biol. Chem., August 3, 2001; 276(32): 30216 - 30223. [Abstract] [Full Text] [PDF]